- PR Newswire•yesterday
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc.
NEW YORK, March 24, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (PETX) Lifshitz & Miller announces investigation on behalf of PETX investors concerning PETX's statements about the commercial viability ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aratana Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – PETX
NEW YORK, March 24, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Aratana Therapeutics, Inc. and certain of its officers. The class action, filed in United States District ...
- Accesswire•3 days ago
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aratana Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Aratana Therapeutics, Inc. ("Aratana" or the "Company") ...
PETX : Summary for Aratana Therapeutics, Inc. - Yahoo Finance
Aratana Therapeutics, Inc. (PETX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||3.14 x 100|
|Ask||5.95 x 4000|
|Day's Range||4.99 - 5.22|
|52 Week Range||4.85 - 10.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.30|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|